Skip to content

Scarpa´s Fascia in the Formation of Seroma Post Abdominoplasty After Bariatric Surgery

Study of Scarpa´s Fascia in the Formation of Seroma Post Abdominoplasty After Bariatric Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01942707
Enrollment
46
Registered
2013-09-16
Start date
2013-03-31
Completion date
2018-12-31
Last updated
2018-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Seroma

Keywords

Abdominoplasty,Seroma,Bariatric surgery

Brief summary

46 female postbariatric patients will be submitted to anchor-line abdominoplasty with drains insertion. Patients will be randomized to two groups. One group will have the Fascia Scarpa removed and in the other the Fascia Scarpa will be preserved. The drains will be removed when the volume is less than 30 ml in 24 hours. The primary outcome will be the volume of total drainage obtained in the drains of the abdominal region. Secondary outcomes will be the length of time the drains remain and the presence of seroma assessed by ultrasound on the twentieth postoperative day.

Detailed description

Morbid obesity has been increasing in Brazil and the world and bariatric surgery is the most effective and long-lasting treatment. This leads to large weight losses leading to large body deformities due to excess skin and subcutaneous tissue. The most common post-bariatric plastic surgery is post-bariatric abdominoplasty which main complication is seroma. PURPOSE: To evaluate the effect of Scarpa fascia preservation in seroma reduction. METHODS: A total of 46 patients were randomly assigned to two groups. One group will have the Fascia Scarpa removed and in the other the Fascia Scarpa will be preserved. The drains will be removed when the volume is less than 30 ml in 24 hours. The primary outcome will be the volume of total drainage obtained in the drains of the abdominal region. Secondary outcomes will be the length of time the drains remain and the presence of seroma assessed by ultrasound on the twentieth postoperative day.

Interventions

PROCEDUREabdominoplasty with Scarpa's Fascia

During surgical detachment of the abdominal flap the Scarpa´s fascia is preserved.

PROCEDUREAbdominoplasty without Scarpa´s Facia

During surgical detachment of the abdominal flap the Scarpa´s fascia is removed.

Sponsors

Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

The patient will not know if the Scarpa´s fascia has been removed or preserved.

Eligibility

Sex/Gender
FEMALE
Age
24 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* BMI between 22 and 30 Kg/m2 * Female post-bariatric patient

Exclusion criteria

* neoplasms * Diabetes * lymphatic system diseases * abdominal scars except C section and bariatric surgery scars * mental disorders

Design outcomes

Primary

MeasureTime frameDescription
Total Volume of Drainage in ml.number of days required for drain withdrawal (drained volume less than 30 ml in 24 hours) and no later than 10 daysWe will measure the total volume of drainage, in ml, obtained by the drains in the abdominal region. The measure of drainage will be done at the same time (8:00 am) and by the same nurse everyday in all patients until the drain is withdrawn. The drain will be withdrawn when the drained volume is less than 30 ml in 24 hours. Total volume of drainage will be calculated as the sum of the volumes obtained daily.

Secondary

MeasureTime frameDescription
Number of Days Required for Drain Withdrawal.Number of days required for drain withdrawal (drained volume less than 30 ml in 24 hours) and no later than 10 daysNumber of days required for drain withdrawal. The measure of drainage will be done at the same time (8:00 am) and by the same nurse everyday in all patients until the drain is withdrawn. The drain will be withdrawn when the drained volume is less than 30 ml in 24 hours.
Volume of Seroma Assessed by Ultrasound of the Abdominal Wall.Done after 20 days of surgeryAn ultrasound of the abdominal wall will be realized to check the volume of any residual seroma.

Countries

Brazil

Participant flow

Recruitment details

The recruitment began in october 2014 until april 2015 at Hospital Santo Amaro (private hospital), in Guarujá city, Brazil.

Participants by arm

ArmCount
No Keeping Scarpa's Fascia
Abdominoplasty in anchor-line without keeping Scarpa's Fascia. Abdominoplasty in anchor-line: Abdominoplasty in anchor-line was performed in both groups
23
Keeping Scarpa's Fascia
Abdominoplasty in anchor-line keeping Scarpa's Fascia. Abdominoplasty in anchor-line: Abdominoplasty in anchor-line was performed in both groups
23
Total46

Baseline characteristics

CharacteristicNo Keeping Scarpa's FasciaKeeping Scarpa's FasciaTotal
Age, Continuous37.086 years
STANDARD_DEVIATION 8.06
38.1304 years
STANDARD_DEVIATION 8.05
37.6087 years
STANDARD_DEVIATION 8.074
BMI26.4 Kg/m2
STANDARD_DEVIATION 3
28.2 Kg/m2
STANDARD_DEVIATION 1.9
27.3 Kg/m2
STANDARD_DEVIATION 2.6
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
23 Participants23 Participants46 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
Brazil
23 participants23 participants46 participants
Sex: Female, Male
Female
23 Participants23 Participants46 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 230 / 23
other
Total, other adverse events
0 / 230 / 23
serious
Total, serious adverse events
0 / 230 / 23

Outcome results

Primary

Total Volume of Drainage in ml.

We will measure the total volume of drainage, in ml, obtained by the drains in the abdominal region. The measure of drainage will be done at the same time (8:00 am) and by the same nurse everyday in all patients until the drain is withdrawn. The drain will be withdrawn when the drained volume is less than 30 ml in 24 hours. Total volume of drainage will be calculated as the sum of the volumes obtained daily.

Time frame: number of days required for drain withdrawal (drained volume less than 30 ml in 24 hours) and no later than 10 days

ArmMeasureValue (MEAN)Dispersion
Without Scarpa's FasciaTotal Volume of Drainage in ml.428.9 mlStandard Deviation 222.6
With Scarpa's FasciaTotal Volume of Drainage in ml.249.1 mlStandard Deviation 98.2
p-value: 0.003Wilcoxon (Mann-Whitney)
Secondary

Number of Days Required for Drain Withdrawal.

Number of days required for drain withdrawal. The measure of drainage will be done at the same time (8:00 am) and by the same nurse everyday in all patients until the drain is withdrawn. The drain will be withdrawn when the drained volume is less than 30 ml in 24 hours.

Time frame: Number of days required for drain withdrawal (drained volume less than 30 ml in 24 hours) and no later than 10 days

ArmMeasureValue (MEAN)Dispersion
Without Scarpa's FasciaNumber of Days Required for Drain Withdrawal.5.4 daysStandard Deviation 1.9
With Scarpa's FasciaNumber of Days Required for Drain Withdrawal.4.2 daysStandard Deviation 1.2
p-value: 0.012t-test, 2 sided
Secondary

Volume of Seroma Assessed by Ultrasound of the Abdominal Wall.

An ultrasound of the abdominal wall will be realized to check the volume of any residual seroma.

Time frame: Done after 20 days of surgery

ArmMeasureValue (MEAN)Dispersion
Without Scarpa's FasciaVolume of Seroma Assessed by Ultrasound of the Abdominal Wall.21.6 mlStandard Deviation 40.7
With Scarpa's FasciaVolume of Seroma Assessed by Ultrasound of the Abdominal Wall.16.8 mlStandard Deviation 25
p-value: 0.809Wilcoxon (Mann-Whitney)

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026